MedTrace Logo

Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study

NCT03978481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3700

Last updated 2024-11-29

No results posted yet for this study

Summary

In this study, we will observe the long-term survival rate, overall mortality rate, gastric cancer specific mortality rate, and the incidence rate of metachronous cancer in patients who received subtotal gastrectomy, with or without Helicobacter pylori eradication.

Conditions

Interventions

COMBINATION_PRODUCT

Helicobacter pylori eradication (combination therapy)

Antibiotic eradication therapy (triple or quadriple regimen)

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-30
Primary Completion
2020-01-30
Completion
2020-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03978481 on ClinicalTrials.gov